Menu
Log in
Log in


The Canadian Society of

Pharmacology and Therapeutics

Welcome  !

Thanks for being a valued member. Take advantage of all the benefits your membership includes and don't forget to renew.

Log in

CSPT Member log-In / Reset Password / View & Edit Profile

For laptop and desktop users, click the blue person icon located on the left or on top right of your screen.

For mobile (phone) and tablet users, click the black arrow icon located on the top right of your screen.


CSPT membership APP for your iphone, ipad, Android device, and Chromebook.

Apple APP Store


Upcoming events

    • Wednesday, January 29, 2025
    • 12:00 PM - 1:00 PM
    • Zoom (Link will be sent close to the event)
    Register


    Register to join us for our next CSPT members' webinar!

    Evolving options for GLP-1 medicines in the clinic

    Hear from

    Daniel Drucker, MD FRCPC

    Mount Sinai Hospital, Lunenfeld Tanenbaum Research Institute

    Division of Endocrinology, University of Toronto


    Dr. Drucker is an Endocrinologist and Professor of Medicine in the Division of Endocrinology at University of Toronto. He holds the Banting and Best Diabetes Centre Novo Nordisk Chair in Incretin Biology. His laboratory is based in the Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital in Toronto and studies the molecular biology and physiology of the glucagon-like peptides. Dr. Drucker received training in Internal Medicine and Endocrinology from the Johns Hopkins Hospital in Baltimore and the University of Toronto, followed by a fellowship in molecular endocrinology at Massachusetts General Hospital. His discoveries have enabled development of several new GLP-1-based therapies for the treatment of diabetes and obesity and GLP-2 analogues for intestinal failure. Drucker has received numerous international awards for his translational science and has been elected to the Order of Canada, the Canadian Medical Hall of Fame, Fellowship in the Royal Society (London) and the National Academy of Sciences and National Academy of Medicine (USA).

    • Tuesday, June 03, 2025
    • 8:00 AM
    • Thursday, June 05, 2025
    • 1:30 PM
    • Sutton Place Hotel, Vancouver, British Columbia
    Register

    Dear Colleagues and trainees,

    On behalf of the Canadian Society for Pharmacology and Therapeutics, it is our great pleasure to invite you to join us for the 2025 Annual Meeting, set to take place from June 2nd to 5th in beautiful Vancouver, British Columbia. This promises to be an extraordinary event where science, innovation, and collaboration converge in one of Canada’s most stunning cities.

    This year’s theme is “From the Sea to the Sky: Unlocking the mysteries of drug action”. The program is thoughtfully designed to provide a wealth of opportunities for learning, networking, and inspiration, beginning with an industry workshop tailored specifically for students and trainees.

    Over the course of the three main days of the conference, attendees will have the opportunity to explore ground-breaking, unpublished research presented by leading experts from Canada and around the world. The program will feature state-of-the-art symposia, a showcase of top-rated trainee abstracts, and invaluable opportunities to engage in discussions that will influence the future of pharmacology education.

    We are excited to present our keynote speakers:

    Terrance Snutch, PhD

    University of British Columbia


    Keith Humphreys Stanford Health Policy Affiliate Faculty Member

    Keith Humphreys, PhD

    Stanford University, USA

    Pieter Cullis, PhD

    University of British Columbia

    Click for more information

    Click to submit an abstract

    Click to join/renew CSPT membership


Sponsors & Partners section

The Canadian Society of Pharmacology and Therapeutics

Copyright © 2024 CSPT. All rights reserved.

Let's connect:  Email | X(Twitter) | Facebook


Powered by Wild Apricot Membership Software